# NIH Reporter #5R33HL167909-03

A Selective Serotonin Reuptake Inhibitor for Asthma Patients with Frequent Exacerbations

**Recipient:** UT Southwestern Medical Center

**Award Amount:** $789,365.00
**Ceiling:** $789,365.00

**Awarded:** September 01, 2026

**Identifier:** 5R33HL167909-03

Funding supports a clinical trial investigating whether escitalopram can reduce asthma exacerbations and improve asthma control in adults with frequent exacerbations.

### Description

A two-phase clinical trial comparing escitalopram with placebo in adults with moderate to severe persistent asthma and frequent exacerbations. The study will assess steroid-burst need, asthma control, functioning, quality of life, and related measures.

[View original record](https://reporter.nih.gov/search/0ftClcwKYUOEq8QKPKx2lA/project-details/11419909)